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Summary 
The androgen receptor (AR) is activated upon binding of testosterone or dihydrotestosterone and exerts 
regulatory effects on gene expression in androgen target cells. To study transcriptional regulation of the rat 
AR gene itself, the 5’ genomic region of this gene was cloned from a genomic library and the promoter 
was identified. Sl-nuclease protection analysis showed two major transcription start sites, located between 
1010 and 1023 bp upstream from the translation initiation codon. The area surrounding these start sites 
was cloned in both orientations in a CAT reporter plasmid. Upon transfection of the constructs into COS 
cells, part of the promoter stimulated transcription in an orientation-independent manner, but the full 
promoter showed a higher and unidirectional activity. In the promoter/reporter gene constructs, transcrip- 
tion initiated from the same positions as in the native gene. Sequence analysis showed that the promoter of 
the rat AR gene lacks typical TATA and CCAAT box elements, but one SPl site is located at about 60 bp 
upstream from the major start site of transcription. Other possible promoter elements are TGTYCT 
sequences at positions - 174 to - 179, -434 to -439, - 466 to -471, and - 500 to - 505, resembling 
half-sites of the glucocorticoid-responsive element (GRE). Furthermore, a homopurine stretch containing a 
total of 8 GGGGA elements and similar to sequences that are present in several other GC-rich promoters, 
is located between - 89 and - 146 bp upstream from the major start site of transcription. 
Introduction 
Following differentiation of the testis, andro- 
gen action is essential for development of the male 
reproductive tract, virilization and full initiation 
and maintenance of spermatogenesis (Griffin and 
Wilson, 1989). The androgenic hormones testos- 
terone and dihydrotestosterone exert their effects 
on gene expression through binding to the andro- 
gen receptor (AR). The AR belongs to the family 
of ligand-activated transcription factors that in- 
cludes the other steroid hormone receptors as well 
as the thyroid hormone, the retinoic acid and the 
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vitamin D, receptors. The progesterone and gluco- 
corticoid receptor are structurally most closely 
related to the AR (Tilley et al., 1989). 
0303-7207/90/$03.50 0 1990 Elsevier Scientific Publishers Ireland, Ltd. 
Recently, the cDNAs encoding the human and 
rat AR have been cloned (Chang et al., 1988; 
Lubahn et al., 1988; Trapman et al., 1988). The 
rat AR mRNA is approximately 10 kb, containing 
large 5’ and 3’ untranslated regions (UTRs) of 
approximately 1 and 7 kb respectively. The open 
reading frame encodes a protein with 902 amino 
acid residues. The rat and human AR mRNAs 
show a high degree of sequence similarity in the 
coding regions and the 5’ UTRs. 
The regulation of AR protein levels may con- 
stitute an important level of control at which the 
physiological effects of testosterone can be mod- 
ulated. In the testis, AR protein is expressed in 
Sertoli cells, Leydig cells and peritubular cells, but 
not in the developing germ cells (Grootegoed et 
al., 1977; Buzek and Sanborn, 1988). Recently, it 
has been shown that both follicle-stimulating 
hormone (FSH) and testosterone can stimulate 
AR protein levels in cultured Sertoli cells from 
immature rats (Verhoeven and Cailleau, 1988; Blok 
et al., 1989). However, only FSH stimulated the 
amount of AR mRNA, whereas testosterone had 
no effect on mRNA expression (Blok et al., 1989). 
In other tissues, including prostate, kidney, brain 
and epididymis, the AR mRNA content is down- 
regulated by testosterone (Quarmby et al., 1990). 
The cellular amount of AR mRNA may be 
regulated at the level of transcription, but also 
through alteration of its stability. To study a pos- 
sible regulatory effect of testosterone and FSH on 
the rate of AR gene transcription, the AR gene 
promoter should be defined. Here we report the 
identification and characterization of the rat AR 
gene promoter. 
Materials and methods 
Isolation of 5’ genomic rat AR clones 
A rat genomic library was constructed by clon- 
ing rat DNA that had been partially digested with 
Mb01 into the BamHI site of XEMBL3. This 
library (1.7 X lo6 independent plaques) was 
screened using human AR probes corresponding 
to the 5’ region of the human AR first exon 
(Faber et al., 1989). Hybridization was carried out 
using standard methods (Maniatis et al., 1982) 
under conditions of low stringency. Positive clones 
were selected and rescreened to obtain purified 
single plaques. Five independent clones were iso- 
lated: GrAR2, 3, 4, 6, 7. 
Subcloning and sequencing 
Several restriction fragments derived from 
GrAR2 were subcloned into pGEM7 (Promega, 
Madison, WI, U.S.A.) using standard techniques 
(Maniatis et al., 1982). Partial overlapping clones 
were sequenced by dideoxy-chain termination 
(Sanger et al., 1977) in two orientations using T7 
polymerase (Pharmacia, Uppsala, Sweden). Dou- 
ble-stranded plasmid DNA was used as a tem- 
plate. The promoter/ reporter gene constructs were 
prepared as follows: The genomic Hind111 frag- 
ment (- 296/+ 120) was cloned in the Hind111 
site of the polylinker from the pCATENH vector 
(Promega) in the antisense direction (HASCAT). 
pGEM7H3.1, containing the Hind111 fragment 
(- 296/+ 120), was partially cut with NheI, 
treated with Klenow enzyme and dNTPs to pre- 
pare blunt ends, followed by a complete Hind111 
digestion. Subsequently, the appropriate HindIII- 
NheI fragment (- 296/ + 97) was isolated from 
low-melting-point agarose. The fragment was 
ligated into pCATENH which had been cut with 
XbaI and blunt-ended with Klenow enzyme fol- 
lowed by a second digestion with Hind111 
(HSCAT). The PstI fragment (- 507/ + 912) was 
cloned into the PstI site from pCATENH in the 
antisense direction (PASCAT). pGEM7E3, con- 
taining the EcoRI fragment (- 570/ + 1005) was 
cut with KpnI, treated with T4 polymerase and 
dNTPs to create blunt ends, followed by digestion 
with Pst I. The KpnI-PstI fragment was isolated 
from low-melting-point agarose and cloned into 
pCATENH (PSCAT), which had been cut with 
HindIII, blunt ended with Klenow and digested 
with PstI. The insertion of the correct fragment in 
the desired orientation was checked by restriction 
enzyme digestion. 
RNA isolation 
Frozen tissues and cultured cells were lysed and 
homogenized in 3 M LiC1/6 M ureum, and left on 
ice for several hours. The RNA was pelleted 
through ultracentrifugation (25 X lo3 rpm, 25 min, 
SW40 rotor). The pellet was dissolved in 0.1% 
(w/v) sodium dodecyl sulfate (SDS) and proteins 
were removed by repeated phenol extraction and a 
single proteinase K treatment in 0.1% (w/v) SDS. 
After precipitation the RNA was dissolved in a 
small volume of water and the amount of RNA 
was determined by spectrophotometric optical 
density (OD) measurement at 260 nm. RNA was 
stored in 0.3 M NaAc/70% ethanol at - 2O“C. 
SI-nuclease protection assay 
pGEMH3.1 was cut with HindIII, dephos- 
phorylated and end-labeled with T4 polynucleo- 
tide kinase and [Y-~‘P]ATP according to Maniatis 
et al. (1982). The Hind111 fragment was subse- 
quently isolated from low-melting-point agarose 
and dissolved in 0.3 M NaAc (pH 5.2). Approxi- 
mately 0.5-l x lo5 cpm were precipitated with the 
appropriate amount of total RNA. After centrifu- 
gation, the pellet was dissolved in hybridization 
buffer containing 80% (v/v) deionized formamide, 
40 mM Pipes (pH 6.3) 0.4 M NaCl and 1 mM 
EDTA according to Favaloro et al. (1980). The 
samples were denatured for 3 mm at 90°C fol- 
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lowed by an overnight hybridization at 55O C. 
Sl-nuclease (Boehringer Mannheim, Mannheim, 
F.R.G.) digestions (Favaloro et al., 1980) were 
carried out for 1 h at 37O C or for 3 h at 20°C 
with similar results. The protected DNA frag- 
ments were analyzed on a 6% or 8% polyacryl- 
amide sequencing gel. 
Cell culture and transient transfection assays 
COS cells were grown in Dulbecco’s modifica- 
tion of Eagle’s medium (Gibco BRL, Grand Is- 
land, NY, U.S.A.), supplemented with 10’ IU/l 
of penicillin, 100 mg/l streptomycin and 5% fetal 
calf serum. All cultures were maintained at 3°C 
under an atmosphere of 5% CO, in air. Before 
transfection, cells were plated in 6 cm diameter 
culture dishes (Nunclon, Roskilde, Denmark) at 
approximately 10% confluence and cultured for 24 
h. Transfections were carried out according to 
Graham and van der Eb (1973) using 10 pg of 
plasmid DNA per dish. The cells were shocked 24 
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Fig. 1. Schematic representation of isolated lambda clones, containing genomic rat AR sequences (GrAR2, 3,4, 6, 7). Part of GrAR2 
is shown in more detail. The 5’ end of the published rat AR cDNA (Lubahn et al., 1988) is indicated. The horizontal arrows show the 
sequence strategy. The horizontal line above the restriction map of GrAR2 represents the probe that was used for the Sl-nuclease 
protection assays. The asterisk indicates the site used for end-labeling by [Y-‘~P] ATP. A = Suu3A, E = EcoRI, H = HindUI, 
K = KpnI, N = NheI, P = PstI, S = SalI. 
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h later for 2 min with 15% glycerol in phosphate- 
buffered saline (PBS), and 48 h after transfection 
the cells were harvested and broken by three cycles 
of freezing and thawing. After centrifugation, su- 
pernatants were assayed for CAT activity as de- 
scribed by Gorman et al. (1982). A transfection 
with pSV2CAT was included in each experiment 
as a control to compare the transfection efficien- 
cies of the different experiments. 
Results 
Isolation and characterization of 5’ genomic rat AR 
clones 
A rat liver genomic library was screened with 
human AR cDNA probes representing the 5’ end 
of the AR mRNA. Five independent overlapping 
clones were isolated as presented in Fig. 1. GrAR2 
contained the farthest 5’ extending sequences and 
this clone has been used for subsequent studies. 
Based upon hybridization results, we have sub- 
cloned and sequenced several restriction frag- 
ments derived from GrAR2. The sequencing 
strategy is also shown in Fig. 1 and the obtained 
sequence is presented in Fig. 2. The 3’ end of this 
sequence (117 bp) is identical to the published 5’ 
end of the rat AR cDNA (Lubahn et al., 1988). 
Identification of the 5’ end of the rat AR mRNA 
In order to locate the cap site of the rat AR 
mRNA we have performed Sl-nuclease protection 
assays. A genomic Hind111 fragment that sur- 
-510 CA~AATCEMGGGACTCl’CCC?lT~TGGGCCCTGGGGA 
- 3 3 0 TAGGCITGTCIG’ITAAAAAA TCGCTCCAAG’ITAUGCITC!‘KCTlTGGAGTCTAAAGCCC 
-270 GGTTCCGAAAAA CAAGTGGTATPTGGGG AUAGGGGTCTTCAGAGGCl’ACAGGGAGTCCT 




-90 PGGCAGGGA ~C!CGAGACTCACAAACn;TTG 
** ** 




Fig. 2. Sequence of the 5’ genomic region of the rat AR gene containing putative promoter elements. The + 1 position is defined at 
the major transcriptional start site. The asterisks above the sequence indicate the other start sites. Putative promoter elements are 
bold-faced: TGTYCT and AGAACA, the homopurine stretch and the CC box. The possible splice acceptor site is underlined and 










Fig. 3. Sl-nuclease protection assay of the 5’ genomic Hind111 
fragment. Protected fragments obtained with 50 pg of total 
testis RNA (lane I), and 50 pg of total spleen RNA (lane 2) 
are shown. The triangle indicates intact probe, and arrows 
indicate the major bands. The numbers on the right represent 
the lengths of the marker DNA in bp. 
rounds the 5’ end of the cDNA was used as a 
probe (Fig. 1). Total RNA preparations from 21- 
day-old rat testis or spleen were hybridized to the 
end-labeled DNA probe, and subsequently the 
Sl-nuclease digestion was carried out; Fig. 3 shows 
the resulting protected DNA fragments after anal- 
ysis on a denaturing polyacrylamide gel. 
Using total testis RNA, two pronounced bands 
were observed (Fig. 3; lane 1). The 5’ ends of the 
two major bands map just upstream from the 5’ 
end of the published rat AR cDNA which is 
located in Fig. 2 at position + 5. Using total RNA 
derived from spleen, an AR-negative tissue 
(Lubahn et al., 1988), no labeled DNA fragments 
protected from Sl-nuclease digestion were de- 
tected. The Sl-nuclease digestion has been carried 
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out at 37 o C as well as at 20°C and similar results 
were obtained at both temperatures (not shown). 
We have also performed primer extension anal- 
ysis as described by Krug and Berger (1987) to 
identify the transcription start sites using another 
method. However, this method did not yield re- 
sults, most likely because the RNA was present in 
a conformation which interfered with AMV re- 
verse transcriptase activity. 
Structure of the 5’ genomic region of the rat AR 
gene 
The finding that different bands were obtained 
with the Sl-nuclease protection assay strongly im- 
plies the presence of multiple start sites of tran- 
scription, a feature that is common to most pro- 
moters that lack a TATA box. In concordance 
with this, sequence analysis of the 5’ genomic 
region shows that no typical TATA or CCAAT 
box is present (Fig. 2). However, several structural 
elements indicative of a promoter can be indi- 
cated. The genomic region from - 1 to - 300 has 
an overall G/C content of 588, and one SPl site 
(GGCGGG) is located around position -60 
within an uninterrupted stretch of G/C residues. 
Furthermore, a homopurine stretch containing a 
total of eight GGGGA elements is located be- 
tween - 89 and - 146 bp upstream from the major 
start site of transcription. These GGGGA se- 
quences might represent promoter elements (see 
Discussion). 
Other possible promoter elements in this region 
are the TGTYCT consensus elements that are 
present at positions -174 to -179, -434 to 
- 439, -466 to -471, and - 500 to - 505, and 
which can be considered as glucocorticoid-respon- 
sive element (GRE) ‘half sites’. The GRE consists 
of a palindromic pair of hexameric TGTYCT se- 
quences separated by three nucleotides (Klock et 
al., 1987). It should be noted that the 5’ genomic 
region also contains a possible splice acceptor site 
(Fig. 2). 
Functional promoter activity in the 5’ genomic re- 
gion of the rat AR gene 
From the above described results, it is not clear 
whether the protected bands are derived from 
different start sites of transcription, or might re- 
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Fig. 4. Promoter constructs cloned into the pCATENH vector. The promoter fragments and the genomic region from which they 
were derived are shown. Arrows pointing to the right indicate the sense orientation. A schematic drawing of the pCATENH vector 
shows the relative positions of the polylinker (open box), the CAT gene, and the SV40 enhancer (closed boxes). Restriction enzyme 
abbreviations are as in Fig. 1. 
sult from the use of a splice acceptor site: The to determine that the region shown in Fig. 2 
sequence S’TTTCCACCTCCAG3’ is located in indeed represents the rat AR gene promoter. 
the area that contains the supposed start sites of Promoter trap constructs were used to test the 
transcription (Fig. 2) and is in accordance with a functional capacity of the putative promoter. The 
possible intron/exon splice acceptor site. Conse- cloning vector pCATENH (described in Materials 
quently, further experimental evidence was needed and Methods) contains the CAT reporter gene and 
12345678 9 10 11 12 
M C CATENH HSCAT HASCAT PSCAT PASCAT 
Fig. 5. Rat AR promoter activity in COS cells. CAT activity in COS cells which were transfected with: no DNA (M; lane l), 
PSVZCAT (C; lane 2), pCATENH (lanes 3 and 4), HSCAT (lanes 5 and 6), HASCAT (lanes 7 and 8), PSCAT (lane 9 and lo), 
PASCAT (lanes 11 and 12). The S denotes the position of the substrates in the chromatogram, and the A is located at the position of 
the acetylated products of the enzymatic reaction. 
a SV40 enhancer sequence, but no promoter. Two 
types of constructs were made, which contained 
the putative promoter sequences and flanking re- 
gions in either the sense or antisense orientation 
with respect to the CAT reporter gene. A sche- 
matic representation of the different constructs is 
shown in Fig. 4. After transfection into COS cells, 
the stimulatory effect of the different 5’ genomic 
fragments on the rate of CAT gene transcription 
was determined by performing CAT assays (Fig. 
5). pSV2CAT, the positive control plasmid that 
contains a SV40 enhancer and promoter, showed a 










Fig. 6. Analysis of transcriptional start sites in promoter/ 
reporter gene constructs. The probe shown in Fig. 1 was 
hybridized to RNA extracted from: COS cells transfected with 
PSCAT (lane 1; 20 pg), COS cells transfected with PASCAT 
(lane 2; 20 pg), and total testis (lane 3; 60 pg). The triangle 
points to the intact probe and the arrows indicate the major 
protected fragments. The numbers on the right indicate the 
lengths of the marker DNA in bp. 
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high CAT activity as compared with pCATENH. 
The construct HSCAT as well as the antisense 
analogue HASCAT stimulated the transcription of 
the CAT gene several fold, as compared 
to the background activity of the parent vector 
pCATENH. These constructs contain about 300 
bp of possible promoter sequences and approxi- 
mately 100 bp of the 5’ UTR. The larger con- 
struct, PSCAT, that extends 150 bp further up- 
stream and 850 bp further downstream than 
HSCAT and HASCAT, resulted in a somewhat 
higher CAT expression relative to HSCAT and 
HASCAT. In contrast, PASCAT, identical to 
PSCAT but containing the promoter in the anti- 
sense orientation, did not show stimulation of 
CAT activity. 
To investigate whether transcription of the pro- 
moter/CAT reporter gene constructs starts at the 
same sites as the transcription of the wild type AR 
promoter, we performed Sl-nuclease protection 
assays with RNA extracted from the transfected 
COS cells, using as a probe the genomic Hind111 
fragment that had also been used to locate the cap 
site in our previous experiment. The assay was 
performed on total cellular RNA derived from 
COS cells transfected with either the PSCAT 
(sense) or PASCAT (antisense) construct (Fig. 6). 
Using the sense and anti-sense rat AR genomic 
sequence constructs, stable transcripts were ob- 
tained in both orientations, although CAT-gene 
derived sequences are only included in the PSCAT 
transcripts. This experiment was performed to 
show that the 5’ ends of the protected fragments 
in RNA from the transfected cells mapped at 
exactly the same positions as those observed using 
RNA from rat testis (Fig. 6; lane C). It can be 
concluded, therefore, that the promoter region in 
PASCAT as well as PSCAT directs transcription 
from the correct initiation sites and on the correct 
DNA strand. 
Discussion 
Structural features of the rat AR gene promoter 
From the present results it is concluded that 
the minimal promoter of the rat AR gene is located 
within the area from position + 100 to -300 in 
the 5’ genomic region of the rat AR gene. The 
sequence upstream of position + 1 is not effi- 
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ciently transcribed into mRNA as shown by Sl- 
nuclease protection analysis. A regulatory func- 
tion of the largely untranscribed sequence - 1 to 
- 300 is reflected in the presence of known se- 
quences in this area that have been proven to be 
functional elements of other promoters. 
First, a GC box (GGCGGG) is located around 
position -60. This sequence is identical to a re- 
cognition site for the transcription factor SPl that 
has been shown to activate the transcription of 
several genes (Saffer and Singer, 1984). 
Second, a homopurine stretch of 67 bp, located 
between positions -79 and - 146. Within this 
region a total of eight repeats of the sequence 
GGGGA is present. Several other genes also con- 
tain purine-rich sequences in the promoter 
(Christophe et al., 1989; Claessens et al., 1989; 
Watson and Milbrandt, 1989; Young et al., 1989) 
some including the GGGGA element (Watson 
and Milbrandt, 1989; Young et al., 1989). No 
functional role has yet been assigned to this se- 
quence motive, although homopurine stretches are 
known to contain sites that are sensitive to Sl- 
nuclease digestion indicating an irregular DNA 
structure (Claessens et al., 1989; Young et al., 
1989). The GGGGA element could very well rep- 
resent a regulatory protein binding site. For exam- 
ple, the transcription factor ETF can bind to 
sequences that contain CCCC or GGGG repeats 
separated by one nucleotide. Through binding to 
these consensus repeats, ETF specifically enhances 
transcription from promoters which do not con- 
tain a TATA box (Kageyama et al., 1989). The P2 
promoter of the c-myc gene also contains a GG- 
GGA element which is involved in protein bind- 
ing and promoter function. The sequence element 
GGGGAGGGA, located 48 bp upstream of the 
start site of transcription in the c-myc P2 promo- 
ter, can be specifically bound by protein in a gel 
retardation assay and is capable of increasing the 
promoter activity (Hall, 1990). 
Finally, TGTYCT elements are present at four 
different positions between - 174 and -505 in 
the promoter region. A glucocorticoid responsive 
element (GRE) consists of a palindromic pair of 
the hexameric TGTYCT sequence, separated by 
three nucleotides (Klock et al., 1987). In a random 
distribution, the TGTYCT sequence would be ex- 
pected to occur approximately once in every lo3 
bp. It might be suggested that this non-palindromic 
sequence, either as repeat, or together with flank- 
ing sequences, might also have some function in 
steroid hormone responsive promoters in general. 
In this respect, it is of interest that TGTYCT 
sequences are present in the promoter of the 
androgen-dependent prostatic binding protein 
genes Cl, C2 and C3 (Claessens et al., 1989a). 
Furthermore, fragments from the promoter and 
first intron of the C3 gene that contain this con- 
sensus sequence have been shown to bind AR- 
steroid complex (Rushmere et al., 1987). Only the 
intron-derived sequence could confer androgen re- 
sponsiveness to a heterologous promoter and this 
effect could be annulled by a single point muta- 
tion in one of the two TGTYCT motives that were 
located in this area (Claessens et al., 1989b). 
Recently, we have also cloned the human AR 
gene promoter (Faber et al., manuscript in prep- 
aration). Comparison of the rat and human se- 
quences indicates that the AR promoter shows a 
similar structural organization in these two species. 
The major start sites of transcription are located 
at the same positions within a region that shows a 
high degree of sequence similarity. The human AR 
gene promoter also contains one SPl site and a 
homopurine stretch, but no other conserved ele- 
ments are located within 570 bp upstream from 
the major transcription start site. 
Two major start sites of transcription and a putative 
splice acceptor site are located within the same 
region 
The results of the Sl-nuclease protection assay 
indicated the presence of two major start sites of 
transcription between 1010 and 1023 bp upstream 
from the translation initiation codon. However, it 
is important to exclude that the results reflect the 
presence of an intron/exon boundary (splice 
acceptor site), or that the results are derived from 
non-specific hybridization. This is indicated by the 
following. First, the two major bands were not 
found when spleen derived RNA was used. Sec- 
ond, RNA from COS cells expressing the promo- 
ter-trap constructs PSCAT and PASCAT, resulted 
in the same Sl-nuclease protection pattern as that 
obtained using total testis RNA. In PSCAT and 
PASCAT, the possible splice acceptor site is sep- 
arated from any possible splice donor site in the 
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genome. It can be concluded therefore, that the 
two double bands observed in the Sl-nuclease 
assay are derived from hybridization of the probe 
to AR mRNAs, and represent two start sites of 
transcription. 
The minimal promoter of the rat AR gene is located 
within the 5’ genomic region between positions 
+lOO and -300 
Promoter trap constructs were used to test the 
functional capacity of the DNA sequences sur- 
rounding the start sites of transcription to act as a 
promoter. By cloning 5’ genomic sequences in 
either the sense or antisense orientation, ad- 
ditional information about the direction of tran- 
scription initiation should be obtained. The frag- 
ment that spans the region from -296 to + 120 
(constructs HSCAT and HASCAT) activates tran- 
scription in an orientation-independent manner. 
This is not surprising from what is currently known 
about the characteristics of promoters lacking 
typical TATA or CCAAT box sequences, also 
called housekeeping or GC-rich promoters. The 
transcription factors SPl and ETF can activate 
transcription on both DNA strands (Saffer and 
Singer, 1984; Kageyama et al., 1989) and the 
upstream half of the calcium-dependent protease 
(CANP) gene promoter shows activity in either 
orientation (Hata et al., 1989). 
However, a larger construct of the rat AR 5’ 
genomic region appears to function in one direc- 
tion only. This can be concluded from the ob- 
servation that the transcriptional activity is stimu- 
lated by PSCAT that contains the promoter frag- 
ment in the sense orientation, but not by the 
PASCAT antisense construct. PSCAT and 
PASCAT contain a promoter fragment which in- 
cludes additional regulatory up- and downstream 
sequences as compared to the H(A)SCAT con- 
structs. 
The start sites of transcription that were func- 
tional in the promoter/reporter gene constructs in 
the transfected COS cells were found to map at 
exactly the same positions as the start sites that 
were identified using testis RNA. Hence, the pro- 
tected DNA fragments that were obtained with 
RNA transcribed from both the sense and anti- 
sense constructs can only be the result of tran- 
scription initiation. Intron/exon splicing could not 
have resulted in the same protected fragments 
from either orientation of the promoter fragment, 
unless the splice donor site would be present in 
the genornic fragment. However, this is very un- 
likely not only because we have shown that the 
different constructs resulted in transcription start- 
ing at the rat AR gene promoter, but also because 
there is no splice donor consensus sequence pres- 
ent in the tested promoter reporter gene con- 
structs. 
No consensus cyclic AMP responsive element 
(CRE) is located within or near the AR gene 
promoter region. This may point to a complex and 
indirect regulatory mechanism for the effect of 
FSH on AR mRNA expression in Sertoli cells; the 
transcription of several CRE-containing genes in 
Sertoli cells is stimulated by FSH and/or dbcAMP 
(Hall et al., 1988; Klaij et al., 1990). By transfec- 
tion of AR promoter/reporter gene constructs 
into Sertoli cells, the upstream regions and possi- 
ble regulatory elements of the rat AR promoter 
will be functionally analyzed. 
In conclusion, the rat AR gene promoter lacks 
TATA and CCAAT box elements, but it contains 
one SPl site and several other possible binding 
sites for transcription factors. Part of the promo- 
ter can function in an orientation-independent 
manner, but the full promoter shows a higher and 
unidirectional activity. 
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Note added in proof 
The findings described in the present paper are 
in agreement with recently published data con- 
cerning the promoter of the human androgen re- 
ceptor gene (Tilley et al., J. Biol. Chem. 265 (1990) 
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